期刊文献+

牛磺酸和FK506对HepG2细胞胆固醇水平的影响

Effect of Taurine and FK506 on cholesterol levels in HepG2 cells
下载PDF
导出
摘要 目的:以总胆固醇(Total cholesterol,TC)、游离胆固醇(Free cholesterol,FC)和胆固醇酯(Cholesterol ester,EC)为评价指标,探讨牛磺酸对FK506诱导肝癌细胞Hep G2细胞胆固醇水平代谢异常的影响。方法:首先建立损伤模型,加终浓度为1、5和10μg/m L的FK506,分别在培养24、48 h后测定细胞存活率以及胞内TC、FC和EC水平,确定FK506处理的终浓度;在此基础上,再添加终浓度为0.1、1、10和20 mmol/L的牛磺酸,分别培养24、48 h,测定细胞内TC、FC和EC水平。结果:培养24、48 h,5和10μg/m L FK506处理都使细胞TC、FC水平明显升高(p<0.05),EC水平没有明显变化,但10μg/m L FK506作用48 h时,细胞存活率显著下降到70%,因此确定FK506处理的终浓度为5μg/m L。在FK506(5μg/m L)预处理6 h后,0.1、1、10和20 mmol/L的牛磺酸作用24、48 h都可显著降低FK506诱导的细胞TC、FC水平升高(p<0.05),但作用24 h的效果优于48 h,以20 mmol/L作用24 h降胆固醇效果最佳。结论:FK506通过增加FC诱导Hep G2细胞胆固醇水平升高,而牛磺酸通过降低FC改善了细胞高胆固醇水平。 Objective : The aim of present study was to investigate the effects of Taurine on abnormal cholesterol metabolism in HepG2 cells induced by tacrolimus with total cholesterol (TC), free cholesterol (FC)and cholesterol ester (EC)as the evaluation indexes.Methods : Cell survival rate and the levels of intracellular TC, FC, EC were detected after the cells were cultured for 24 and 48 h in DMEM supplemented with FKS06 at final concentrations of 1,5,10 μg/mL, respectively. The concentration of FK506 was determined which was used to test cholesterol lowering effect of Taurine.Then, Taurine was added to the DMEM with final concentration of 0.1,1,10 and 20 mmol/L after the cells were cultured with FK506 for 6 h and the levels of intracellular TC, FC and EC were detected after the turther incubation for 24 and 48 h. Results: The levels of intracellular TC and FC but not EC were significantly increased after the cells were cultured in the presence of 5 and 10 μg/mL FK506 for 24 h and 48 h ( p 〈 0.05 ) , but 10 μg/mL FK506 for 48 h resulted in cell survival rate decreased to 70% significantly.Therefore,5 μg/mL FK506 was selected as the treatment dose in the following experiments. With the FK506 (5 μg/mL)pretreatment for 6 h, Taurine (0.1,1,10 and 20 mmol/L) supplementation for 24 and 48 h could significantly reduced the evaluated TC,FC levels in cells induced by the FK506 (p 〈 0.05) , and showing a superior effect at 24 h than at 48 h. 20 mmol/L Taurine showed the best cholesterol lowing effect after 24 h treatment.Conclusion: FK506 increased the cholesterol level of HepG2 ceils by increasing FC,while Taurine reduced the high cholesterol level of cells by decreasing FC.
作者 曹雪莲 赵玉星 郭俊霞 张静 陈文 CAO Xue- lian ZHAO Yu- xing GUO Jun- xia ZHANG Jing CHEN Wen(College of Biochemical Engineering, Beijing Union University,Beijing 100023, China)
出处 《食品工业科技》 CAS CSCD 北大核心 2017年第6期350-353,共4页 Science and Technology of Food Industry
基金 北京市教委科技计划面上项目(KM201511417014) 北京市自然科学基金资助项目(5142004)
关键词 牛磺酸 FK506 胆固醇 HEPG2细胞 Taurine FK506 cholesterol HepG2 cells
  • 相关文献

参考文献3

二级参考文献25

  • 1向莉,李盾.计算机编程建立肝脏移植患者他克莫司的有效血药浓度范围[J].中国临床药学杂志,2004,13(5):284-287. 被引量:4
  • 2王振,高江平,罗芸,卢锦山,敖建华,肖序仁,洪宝发,石炳毅,薛毅珑.不同浓度他克莫司在体外对胰岛的毒性作用及致糖尿病作用的临床研究[J].中华器官移植杂志,2006,27(11):681-684. 被引量:15
  • 3王振,石炳毅,高江平,罗芸.免疫抑制剂对人胰岛细胞的毒性作用[J].解放军医学杂志,2007,32(1):43-45. 被引量:3
  • 4Vanrenterghem YF, Claes K, Montagnino G, et al. Risk factors for cardiovascular events after successful renal transplantation [ J ]. Transplantation, 2008, 85 ( 2 ):209-216.
  • 5Ghisdal L, Bouchta NB, Broeders N, et al. Conversion from tacroiimus to cyclosporine A for new-onset diabetes after transplantation: a single-centre experience in renal transplanted patients and review of the literature [ J ]. Transpl Int, 2008, 21(2) :146-151.
  • 6Lentine KL, Brennan DC. Statin use after renal transplantation : a systematic quality review of trial-based evidence [ J ]. Nephrol Dial Transplant, 2004, 19 (9) :2378-2386.
  • 7Wolfe RA, Ashby VB, Milford EL, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant [J]. N Engl J Med, 1999, 341(23) :1725-1730.
  • 8Rao PS, Schaubel DE, Jia X, et al. Survival on dialysis post-kidney transplant failure: results from the Scientific Registry of Transplant Recipients [ J ]. Am J Kidney Dis, 2007, 49 (2) :294-300.
  • 9Shimmura H, Tanabe K, Tokumoto T, et al. Analysis of cause of death with a functioning graft : a single-center experience [ J]. Transplant Proc, 2004, 36 (7) :2026-2029.
  • 10Vanrenterghem YF, Claes K, Montagnino G, et al. Risk factors for cardiovascular events after successful renal transplantation [ J ]. Transplantation, 2008, 85 ( 2 ) : 209-216.

共引文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部